Buy MOTS-c (10mg)

MOTS-c Description

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondria-derived peptide discovered in 2015 that functions as a mitochondrial-encoded regulatory signal. The 16-amino acid peptide is encoded by the mitochondrial genome within the 12S rRNA gene and represents an important link between mitochondrial function and metabolism. MOTS-c primarily targets skeletal muscle and acts as a metabolic regulator by activating the AMPK (AMP-activated protein kinase) pathway, which is crucial for cellular energy homeostasis.

Peptide Information

Product Usage: 

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

MOTS-c Research

Research on MOTS-c is still relatively new, but it has attracted significant interest for potential applications in treating metabolic disorders, obesity, diabetes, and possibly age-related conditions. Some studies in animal models have shown promising results, though human clinical applications are still in early research phases.

MOTS-c and Metabolic Regulation

MOTS-c translocates to the nucleus in response to metabolic stress, where it regulates nuclear gene expression. This process is AMPK-dependent and involves interaction with stress-responsive transcription factors, such as NRF2, to modulate genes associated with antioxidant responses and glucose metabolism¹.

MOTS-c activates the AMPK pathway, which is crucial for energy balance and metabolic regulation. This activation helps improve insulin sensitivity and energy dissipation, particularly in conditions like ovariectomy-induced metabolic dysfunction².

MOTS-c has been shown to prevent diet-induced obesity and insulin resistance by enhancing glucose metabolism and targeting skeletal muscle. It inhibits the folate cycle, leading to AMPK activation, which is essential for maintaining metabolic homeostasis³.

In postmenopausal models, MOTS-c treatment reduces fat mass, suppresses inflammatory responses, and sustains brown adipose tissue activity, thereby preventing weight gain and insulin resistance².

Cognitive Decline and Neuroprotection

MOTS-c has demonstrated significant anti-inflammatory properties, which are crucial for neuroprotection. It inhibits the activation of astrocytes and microglia, reducing the production of proinflammatory cytokines such as TNF-α, IL-6, IL-1β, COX-2, and iNOS⁴. This reduction in neuroinflammation is associated with improved cognitive functions and memory in models of Alzheimer’s disease (AD) and traumatic brain injury (TBI)⁵.

The peptide enhances metabolic processes, including lipid β-oxidation, which provides energy to the brain following injury. This metabolic support is vital for maintaining brain function and reducing molecular damage and cell death in TBI models⁴.

MOTS-c has been shown to enhance object and location recognition memory. It improves memory formation and consolidation, which are critical for cognitive function. These effects are particularly evident in models of AD and TBI, where MOTS-c administration leads to significant improvements in memory tasks⁵.

Continued research is needed to fully understand the mechanisms by which MOTS-c exerts its neuroprotective effects and to optimize its delivery methods for clinical applications. This includes exploring its role in other neurodegenerative conditions and refining its use as a therapeutic agent.

Muscle Homeostasis and Physical Decline

MOTS-c enhances skeletal muscle metabolism by regulating nuclear genes related to metabolism and proteostasis. It also aids myoblast adaptation to metabolic stress, which is crucial for maintaining muscle function and preventing atrophy⁶.

MOTS-c treatment in mice has been shown to significantly enhance physical performance across different age groups, including young, middle-aged, and old mice. This suggests its potential in mitigating age-related physical decline⁶.

MOTS-c has been shown to prevent muscle atrophy by reducing myostatin levels, a negative regulator of muscle mass. This effect is mediated through the PTEN/AKT/FOXO1 signaling pathway, which is crucial for muscle growth and maintenance⁷.

In humans, exercise induces the expression of MOTS-c in skeletal muscle and circulation, indicating its role as an exercise-induced regulator of physical capacity and metabolic homeostasis⁶.

MOTS-c shows promise as a therapeutic agent for conditions like sarcopenia and insulin resistance-induced muscle atrophy. Its ability to modulate key signaling pathways and reduce inflammatory cytokines highlights its potential in treating muscle wasting phenotypes⁷.

Longevity and Anti-Aging

A specific polymorphism in the MOTS-c encoding region has been linked to exceptional longevity in certain populations, suggesting a genetic basis for its anti-aging effects⁹.

References

1. Kim, K., Son, J., Benayoun, B., & Lee, C. (2018). The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress.. Cell metabolism, 28 3, 516-524.e7 . https://doi.org/10.1016/j.cmet.2018.06.008.
2. Lu, H., Wei, M., Zhai, Y., Li, Q., Ye, Z., Wang, L., Luo, W., Chen, J., & Lu, Z. (2019). MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. Journal of Molecular Medicine, 97, 473 – 485. https://doi.org/10.1007/s00109-018-01738-w.
3. Lee, C., Zeng, J., Drew, B., Sallam, T., Martín-Montalvo, A., Wan, J., Kim, S., Mehta, H., Hevener, A., De Cabo, R., & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.. Cell metabolism, 21 3, 443-54 . https://doi.org/10.1016/j.cmet.2015.02.009.
4. Li, F., Jia, Y., Fang, J., Gong, L., Zhang, Y., Wei, S., Wu, L., & Jiang, P. (2024). Neuroprotective Mechanism of MOTS-c in TBI Mice: Insights from Integrated Transcriptomic and Metabolomic Analyses. Drug Design, Development and Therapy, 18, 2971 – 2987. https://doi.org/10.2147/DDDT.S460265.
5. Jiang, J., Chang, X., Nie, Y., Shen, Y., Liang, X., Peng, Y., & Chang, M. (2021). Peripheral Administration of a Cell-Penetrating MOTS-c Analogue Enhances Memory and Attenuates Aβ1-42- or LPS-Induced Memory Impairment through Inhibiting Neuroinflammation.. ACS chemical neuroscience. https://doi.org/10.1021/acschemneuro.0c00782.
6. Reynolds, J., Lai, R., Woodhead, J., Joly, J., Mitchell, C., Cameron-Smith, D., Lu, R., Cohen, P., Graham, N., Benayoun, B., Merry, T., & Lee, C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. https://doi.org/10.1038/s41467-020-20790-0.
7. Kumagai, H., Coelho, A., Wan, J., Mehta, H., Yen, K., Huang, A., Zempo, H., Fuku, N., Maeda, S., Oliveira, P., Cohen, P., & Kim, S. (2021). MOTS-c reduces myostatin and muscle atrophy signaling.. American journal of physiology. Endocrinology and metabolism. https://doi.org/10.1152/ajpendo.00275.2020.
8. Mohtashami, Z., Singh, M., Salimiaghdam, N., Ozgul, M., & Kenney, M. (2022). MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. International Journal of Molecular Sciences, 23. https://doi.org/10.3390/ijms231911991.
9. Fuku, N., Pareja-Galeano, H., Zempo, H., Alis, R., Arai, Y., Lucia, A., & Hirose, N. (2015). The mitochondrial‐derived peptide MOTS‐c: a player in exceptional longevity?. Aging Cell, 14, 921 – 923. https://doi.org/10.1111/acel.12389.

Endotoxin MOTS-C

MOTS-c (11356)

MOTS-C (251514)

Endotoxin MOTS-C (251514E)

MOTS-C (251546)

MOTS-C(10167)

×

Disclaimer: For Research Purposes Only

This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides. . .